Citizen Petition Process Should Be Maintained In Current Form - PhRMA
Executive Summary
FDA should not modify its citizen petition regulations, the Pharmaceutical Research & Manufacturers of America maintained in comments to the agency.
You may also be interested in...
Citizen Petitions Cannot Be Used To Block Generics - FDA Proposed Rule
Innovator pharmaceutical companies will not be able to block approval of generic drugs by using the citizen petition mechanism, according to FDA's Nov. 30 proposed rule to revise the petition process.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011